Alzheimer’s disease

Learn about Alzheimer’s disease and dementia research at public forum

Vanderbilt researchers will discuss their groundbreaking studies on Alzheimer’s disease and dementia at an upcoming forum, and the public is invited to attend.

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

Alzheimer’s study establishes way to measure resilience

Vanderbilt researchers have established a new measure of resilience to cognitive impairment in people with asymptomatic Alzheimer’s disease.

Elderly woman holding hands with young caretaker

Vanderbilt study shows people with Alzheimer’s have lower ability to perceive pain

People with Alzheimer’s disease don’t perceive pain as readily as healthy older adults, and this may lead to delays and underreporting of pain. This alteration in pain detection may be one reason that people with Alzheimer’s disease and pain tend to be undermedicated and suffer unnecessarily, a trans-institutional group of Vanderbilt researchers reported recently in BMC Medicine.

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

Investigators explore African ancestry, Alzheimer’s risk

Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia.

1 3 4 5 6 7